Arthneeti
SC

Sumitomo Chemical India Ltd

Q3 FY26Fertilizers & Agrochemicals

Sumitomo Chemical India Ltd Q3 FY26 Results & Presentation Highlights: Capex ₹150 Cr

Q3 FY26 investor presentation: what the company reported on revenue, margins and projects.

Price₹450
Market cap₹23.0K Cr
P/E40.3
Updated24 Sept 2026
Read4 min read

Based on Sumitomo Chemical India Ltd's Q3 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.

The short version

Revenue from operations for Q3FY26 was Rs. Q3FY26 EBITDA: Rs.

From Sumitomo Chemical India Ltd's Q3 FY26 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

  • Revenue from operations for Q3FY26 was Rs. 568.0 crore, down 12% year-on-year from Rs. 641.9 crore in Q3FY25 (Page 10, 5).
  • The decline was due to discontinuation of Animal Nutrition products (Rs. 72 crore impact), softness in domestic agri-input demand, and cautious distributor purchasing (Page 6).
  • Despite lower revenue, gross profit remained flat with gross margin expansion to 47.4% (Page 10).
  • Export revenues grew 14% YoY led by Japan, Africa, and Asia excluding India (Page 6).

2 more points management made on revenue & sales performance

Profitability & Margins

See what Sumitomo Chemical India Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • New CAPEX Plans (Page 25):
  • Second plant for key SCC innovated product at Bhavnagar site for global requirements, ~₹55 crore, targeted completion Q4 FY27 (Jan–Mar 2027).
  • Equipment modification and line readiness at Tarapur for newly launched SCC innovated molecule, ~₹10 crore, targeted completion Q4 FY27 (Jan–Mar 2027).
  • Additional Capex for Special Projects (Page 7):
  • Plant for manufacturing herbicide intermediate at Dahej site, first strategic investment; capex ~₹150 crore, no timeline specified, initial operations to commence using parent company know-how.
  • Fitment at Tarapur to manufacture two additional molecules (one fungicide, one herbicide), capex ~₹10 crore, estimated commercialization Q2 FY28–29.
  • Capacity Expansion (Page 24):

2 more points management made on capital expenditure plans

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

5x potential
1Anya Polytech & Fertilizers Ltd
Rev 2Mar 1
2Dharmaj Crop
Rev 2Mar 2
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 2Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Sumitomo Chemical India Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The investor presentation does not explicitly report any figures or details regarding order book, order inflow, or pending orders. Based on the provided content from the presentation: - There is no mention of "order book," "order inflow," or "pending orders" in the financials, operational overview, or other sections. - The presentation primarily focuses on financial performance, product launches, distribution network, working capital, cash flow, and marketing activities. - No specific data or metrics related to order backlog or inflow are included in the slides or tables presented. Hence, the presentation does not disclose any order book or related pending order information.

Sumitomo Chemical India Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹671 Cr, net profit ₹111 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Sumitomo Chemical India Ltd's management said in earlier quarters

Others in Fertilizers & Agrochemicals this season

  • Dharmaj Crop (Q3 FY26)

    Q3FY26 revenue from operations: ₹1,895 million, a 9% year-on-year (YoY) increase from ₹1,745 million in Q3FY25. Key investor presentation takeaways from Dharmaj

  • Indogulf Cropsci (Q3 FY26)

    The value of these export orders in hand is approximately INR 4 to 5 crores. Key concall takeaways from Indogulf Cropsci's Q3 FY26 earnings call — and how it…

  • Rallis India (Q3 FY26)

    Domestic B2C business growing steadily with 13% growth in Q3; volume expansion despite some price softness. Key concall takeaways from Rallis India's Q3 FY26…

  • Sharda Cropchem (Q3 FY26)

    Capex planned in the range of INR 450-500 crores to support growth and registration activities. Key concall takeaways from Sharda Cropchem Ltd's Q3 FY26…

Compare:vs Coromandel Intervs F A C Tvs UPL

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Sumitomo Chemical India Ltd Q3 FY26 results?

Revenue from operations for Q3FY26 was Rs. Q3FY26 EBITDA: Rs.

What is Sumitomo Chemical India Ltd share price analysis?

Sumitomo Chemical India Ltd currently shows a neutral. The stock trades at a P/E of 40.3 with a market cap of ₹23,003 Cr. Investors should review the full earnings analysis for detailed insights.

Is Sumitomo Chemical India Ltd planning capital expenditure?

New CAPEX Plans (Page 25): - Second plant for key SCC innovated product at Bhavnagar site for global requirements, ~₹55 crore, targeted completion Q4 FY27 (Jan–Mar 2027).

Keep Sumitomo Chemical India Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.